• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纵向免疫分析揭示了与前列腺肿瘤模型中自发免疫编辑相关的独特髓系和 T 细胞表型。

Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model.

机构信息

Columbia Center for Translational Immunology (CCTI), Columbia University Irving Medical Center, New York, New York.

Department of Systems Biology, Columbia University Irving Medical Center, New York, New York.

出版信息

Cancer Immunol Res. 2021 May;9(5):529-541. doi: 10.1158/2326-6066.CIR-20-0637. Epub 2021 Feb 26.

DOI:10.1158/2326-6066.CIR-20-0637
PMID:33637604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8102339/
Abstract

The theory of cancer immunoediting, which describes the dynamic interactions between tumors and host immune cells that shape the character of each compartment, is foundational for understanding cancer immunotherapy. Few models exist that facilitate in-depth study of each of the three canonical phases of immunoediting: elimination, equilibrium, and escape. Here, we utilized NPK-C1, a transplantable prostate tumor model that we found recapitulated the three phases of immunoediting spontaneously in immunocompetent animals. Given that a significant portion of NPK-C1 tumors reliably progressed to the escape phase, we were able to delineate cell types and mechanisms differentially prevalent in equilibrium versus escape phases. Using high-dimensional flow cytometry, we found that activated CD4 effector T cells were enriched in regressing tumors, highlighting a role for CD4 T cells in antitumor immunity. CD8 T cells were also important for NPK-C1 control, specifically, central memory-like cytotoxic CD8 T cells. Regulatory T cells (Treg), as a whole, were counterintuitively enriched in regressing tumors; however, high-dimensional analysis revealed their significant phenotypic diversity, with a number of Treg subpopulations enriched in progressing tumors. In the myeloid compartment, we found that iNOS dendritic cell (DC)-like cells are enriched in regressing tumors, whereas CD103 DCs were associated with late-stage tumor progression. In total, these analyses of the NPK-C1 model provide novel insights into the roles of lymphoid and myeloid populations throughout the cancer immunoediting process and highlight a role for multidimensional, flow-based analyses to more deeply understand immune cell dynamics in the tumor microenvironment.

摘要

癌症免疫编辑理论描述了肿瘤和宿主免疫细胞之间的动态相互作用,这些相互作用塑造了每个肿瘤微环境的特征,是理解癌症免疫治疗的基础。目前几乎没有模型能够深入研究免疫编辑的三个经典阶段:消除、平衡和逃逸。在这里,我们利用了 NPK-C1,这是一种可移植的前列腺肿瘤模型,我们发现它在免疫功能正常的动物中自发地重现了免疫编辑的三个阶段。由于 NPK-C1 肿瘤的很大一部分确实进展到了逃逸阶段,我们能够描绘出在平衡期和逃逸期差异表达的细胞类型和机制。使用高维流式细胞术,我们发现激活的 CD4 效应 T 细胞在消退的肿瘤中富集,这突出了 CD4 T 细胞在抗肿瘤免疫中的作用。CD8 T 细胞对 NPK-C1 的控制也很重要,特别是中央记忆样细胞毒性 CD8 T 细胞。调节性 T 细胞(Treg)整体上在消退的肿瘤中富集;然而,高维分析显示它们具有显著的表型多样性,许多 Treg 亚群在进展中的肿瘤中富集。在髓系细胞中,我们发现诱导型一氧化氮合酶(iNOS)树突状细胞(DC)样细胞在消退的肿瘤中富集,而 CD103 DC 与晚期肿瘤进展相关。总的来说,这些对 NPK-C1 模型的分析为淋巴和髓系细胞在整个癌症免疫编辑过程中的作用提供了新的见解,并强调了多维、基于流式细胞术的分析方法在更深入理解肿瘤微环境中免疫细胞动力学方面的作用。

相似文献

1
Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model.纵向免疫分析揭示了与前列腺肿瘤模型中自发免疫编辑相关的独特髓系和 T 细胞表型。
Cancer Immunol Res. 2021 May;9(5):529-541. doi: 10.1158/2326-6066.CIR-20-0637. Epub 2021 Feb 26.
2
Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma.鼠源性肉瘤肿瘤免疫平衡与免疫逃逸状态的免疫微环境特征。
Cancer Lett. 2013 Oct 28;340(1):124-33. doi: 10.1016/j.canlet.2013.07.038. Epub 2013 Aug 3.
3
Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.调节性 T 细胞耗竭增强了肝癌患者体内由肿瘤抗原 NY-ESO-1b 引发的肿瘤特异性 CD8 T 细胞反应,在体外。
Int J Oncol. 2010 Apr;36(4):841-8. doi: 10.3892/ijo_00000561.
4
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.异二聚体 IL-15 通过涉及 XCL1、IFN-γ、CXCL9 和 CXCL10 的细胞因子网络延迟肿瘤生长并促进肿瘤内 CTL 和树突状细胞积累。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000599.
5
A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.小肠中 CD103+CD8alpha+树突状细胞的一个新亚群表达 TLR3、TLR7 和 TLR9,并诱导 Th1 反应和 CTL 活性。
J Immunol. 2011 Jun 1;186(11):6287-95. doi: 10.4049/jimmunol.1004036. Epub 2011 Apr 27.
6
TLR3 Activation of Intratumoral CD103 Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity.TLR3 激活肿瘤内 CD103+树突状细胞改变肿瘤浸润,赋予抗肿瘤免疫。
Front Immunol. 2019 Mar 20;10:503. doi: 10.3389/fimmu.2019.00503. eCollection 2019.
7
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.肿瘤驻留的Batf3树突状细胞是效应T细胞转运和过继性T细胞治疗所必需的。
Cancer Cell. 2017 May 8;31(5):711-723.e4. doi: 10.1016/j.ccell.2017.04.003.
8
High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors.高剂量分割放疗在前列腺肿瘤中既能诱导抗肿瘤免疫又能诱导免疫抑制反应。
Clin Cancer Res. 2021 Mar 1;27(5):1505-1515. doi: 10.1158/1078-0432.CCR-20-2293. Epub 2020 Nov 20.
9
Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing.肠道CD103⁺树突状细胞在组织选择性T细胞归巢调节中的功能特化。
J Exp Med. 2005 Oct 17;202(8):1063-73. doi: 10.1084/jem.20051100. Epub 2005 Oct 10.
10
Functional Heterogeneity of CD4 Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC.非小细胞肺癌中具有驻留记忆表型的 CD4 肿瘤浸润淋巴细胞的功能异质性。
Front Immunol. 2018 Nov 16;9:2654. doi: 10.3389/fimmu.2018.02654. eCollection 2018.

引用本文的文献

1
Multi-stage mechanisms of tumor metastasis and therapeutic strategies.肿瘤转移的多阶段机制与治疗策略。
Signal Transduct Target Ther. 2024 Oct 11;9(1):270. doi: 10.1038/s41392-024-01955-5.
2
Development of a customizable mouse backbone spectral flow cytometry panel to delineate immune cell populations in normal and tumor tissues.开发一种可定制的鼠标骨干光谱流式细胞术面板,以描绘正常和肿瘤组织中的免疫细胞群体。
Front Immunol. 2024 Mar 27;15:1374943. doi: 10.3389/fimmu.2024.1374943. eCollection 2024.
3
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.抗 PD-1 免疫疗法联合雄激素剥夺治疗可诱导转移性去势敏感性前列腺癌中强烈的免疫浸润。
Cancer Cell. 2023 Nov 13;41(11):1972-1988.e5. doi: 10.1016/j.ccell.2023.10.006. Epub 2023 Nov 2.
4
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response.KLRG1 标记与肿瘤进展和免疫治疗反应相关的肿瘤浸润性 CD4 T 细胞亚群。
J Immunother Cancer. 2023 Sep;11(9). doi: 10.1136/jitc-2023-006782.
5
Automated Detection and Scoring of Tumor-Infiltrating Lymphocytes in Breast Cancer Histopathology Slides.乳腺癌组织病理学切片中肿瘤浸润淋巴细胞的自动检测与评分
Cancers (Basel). 2023 Jul 15;15(14):3635. doi: 10.3390/cancers15143635.
6
Immune mechanisms shape the clonal landscape during early progression of prostate cancer.免疫机制在前列腺癌早期进展过程中塑造了克隆景观。
Dev Cell. 2023 Jun 19;58(12):1071-1086.e8. doi: 10.1016/j.devcel.2023.04.010. Epub 2023 May 5.
7
OncoLoop: A Network-Based Precision Cancer Medicine Framework.OncoLoop:一种基于网络的精准癌症医学框架。
Cancer Discov. 2023 Feb 6;13(2):386-409. doi: 10.1158/2159-8290.CD-22-0342.
8
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.肿瘤微环境中免疫细胞的双重作用:促肿瘤和抗肿瘤作用及其触发因素。
Cancers (Basel). 2022 Mar 25;14(7):1681. doi: 10.3390/cancers14071681.

本文引用的文献

1
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.MYC 和 RAS 共激活标志物在局限性前列腺癌中驱动骨转移和去势抵抗。
Nat Cancer. 2020 Nov;1(11):1082-1096. doi: 10.1038/s43018-020-00125-0. Epub 2020 Oct 19.
2
Intratumoral CD4 T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.肿瘤内 CD4 T 细胞介导人膀胱癌中的抗肿瘤细胞毒性作用。
Cell. 2020 Jun 25;181(7):1612-1625.e13. doi: 10.1016/j.cell.2020.05.017. Epub 2020 Jun 3.
3
A conserved dendritic-cell regulatory program limits antitumour immunity.一个保守的树突状细胞调控程序限制了抗肿瘤免疫。
Nature. 2020 Apr;580(7802):257-262. doi: 10.1038/s41586-020-2134-y. Epub 2020 Mar 25.
4
MHC-II neoantigens shape tumour immunity and response to immunotherapy.MHC-II 新抗原塑造肿瘤免疫和对免疫治疗的反应。
Nature. 2019 Oct;574(7780):696-701. doi: 10.1038/s41586-019-1671-8. Epub 2019 Oct 23.
5
Dendritic cells in cancer immunology and immunotherapy.树突状细胞在癌症免疫和免疫治疗中的作用。
Nat Rev Immunol. 2020 Jan;20(1):7-24. doi: 10.1038/s41577-019-0210-z. Epub 2019 Aug 29.
6
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.高维分析描绘了免疫检查点癌症治疗期间骨髓和淋巴系重塑。
Cell. 2018 Nov 1;175(4):1014-1030.e19. doi: 10.1016/j.cell.2018.09.030. Epub 2018 Oct 18.
7
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.靶向缺氧减轻可恢复 T 细胞浸润并使前列腺癌对免疫治疗敏感。
J Clin Invest. 2018 Nov 1;128(11):5137-5149. doi: 10.1172/JCI96268. Epub 2018 Oct 15.
8
CD4 T cell help in cancer immunology and immunotherapy.CD4 T 细胞在癌症免疫和免疫治疗中的作用。
Nat Rev Immunol. 2018 Oct;18(10):635-647. doi: 10.1038/s41577-018-0044-0.
9
T Cell Dysfunction in Cancer.肿瘤中的 T 细胞功能障碍。
Cancer Cell. 2018 Apr 9;33(4):547-562. doi: 10.1016/j.ccell.2018.03.012.
10
Unlocking the Complexities of Tumor-Associated Regulatory T Cells.解析肿瘤相关调节性 T 细胞的复杂性。
J Immunol. 2018 Jan 15;200(2):415-421. doi: 10.4049/jimmunol.1701188.